The mRNA levels of key lipogenic genes, FASN, SREBP1 and DGAT1, were substantially increased and those of DNMT3A were modestly increased, while SHP mRNA levels were little changed in the NAFLD patients (Fig. 9a). Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.